Citation Impact
Citing Papers
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
2006 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation
2007
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Ulcerative Colitis
2011 Standout
Ibuprofen-like activity in extra-virgin olive oil
2005 StandoutNature
Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: A review of published adduct types and levels in humans
2007
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Small‐Molecule Affinity Ligands for Protein Purification: Combined Computational Enrichment and Automated In‐line Screening of an Optically Encoded Library
2010 StandoutNobel
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Imaging in the era of molecular oncology
2008 StandoutNature
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Hypoxia and Inflammation
2011 Standout
Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer
2005
Accumulation of lipid peroxidation-derived DNA lesions: Potential lead markers for chemoprevention of inflammation-driven malignancies
2005
Gold(I)‐Catalyzed Tandem Reactions Initiated by 1,2‐Indole Migrations
2008
4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest
2007
Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer
2003
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
1997
Lessons from Hereditary Colorectal Cancer
1996 Standout
Long-term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?
2000
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts
2000
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
1994 Standout
The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients*
2011
The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
1995
A month–long effect from a single injection of microencapsulated human growth hormone
1996
Sulindac Inhibits Activation of the NF-κB Pathway
1999
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers
1998
New Imaging Techniques at Colonoscopy: Tissue Spectroscopy and Narrow Band Imaging
2005
Immune Thrombocytopenic Purpura
2002 Standout
The microenvironment of the tumour–host interface
2001 StandoutNature
High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases
2009
Diagnostics of Inflammatory Bowel Disease
2007
Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura
2000
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Direct Targeting of Rab‐GTPase–Effector Interactions
2014
Hereditary Colorectal Cancer
2003 Standout
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 Standout
Genetic predisposition to colorectal cancer
2004
Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
2003
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
2005
Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment
1994
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Eicosanoids and the gastrointestinal tract
1995
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Drugging the undruggable RAS: Mission Possible?
2014
Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions
1997
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Valorization of Biomass: Deriving More Value from Waste
2012 StandoutScience
5-Hydroxymethylfurfural (HMF) as a building block platform: Biological properties, synthesis and synthetic applications
2011
Polymeric Systems for Controlled Drug Release
1999 Standout
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
N-Heterocyclic Carbenes in Late Transition Metal Catalysis
2009 Standout
Strategien zur Modulation von Protein‐Protein‐Wechselwirkungen mit synthetischen Substanzen
2005
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
1997 StandoutScience
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
1997 StandoutScience
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Colon cancer chemopreventive drugs modulate integrin-mediated signaling pathways.
2000
Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho
2003 Science
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Apoptosis and APC in colorectal tumorigenesis.
1996
Works of G Winde being referenced
The new sulindac derivative IND 12 reverses Ras-induced cell transformation.
2002
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment
1995
New indene-derivatives with anti-proliferative properties
2002
The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration
1993
Cost containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: a prospective randomized double-blind controlled study
2000
Increased levels of promutagenic etheno-dna adducts in colonic polyps of FAP patients
2000
Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention
1998
Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma
2009
Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis
1997
Fluorescence Endoscopy Using a Fluorescein-Labeled Monoclonal Antibody Against Carcinoembryonic Antigen in Patients with Colorectal Carcinoma and Adenoma
2002
Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test
2005
Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP
1997
Sulindac sulfide inhibits Ras signaling
1998
Increased Etheno-DNA Adducts in Affected Tissues of Patients Suffering from Crohn’s Disease, Ulcerative Colitis, and Chronic Pancreatitis
2006
Clinical and functional results of abdominal rectopexy with absorbable mesh-graft for treatment of complete rectal prolapse.
1993
Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
1996